UCL: uCloudlink Reports Sequential Improvement in Q1 as its Recovery Continues
By Lisa Thompson
NASDAQ:UCL
READ THE UCL RESEARCH REPORT
TLSA: Nasally-administered Foralumab Trial in SPMS Patient
By John Vandermosten, CFA
NASDAQ:TLSA | LSE:TILS
READ THE FULL TLSA RESEARCH REPORT
AEMD: Added Liquidity to Advance Hemopurifier
By M. Marin
NASDAQ:AEMD
READ THE FULL AEMD RESEARCH REPORT
PLX: 1Q:21 Results & Next Steps
By John Vandermosten, CFA
NYSE:PLX
READ THE FULL PLX RESEARCH REPORT
SNGX: HyBryte™ Conditionally Accepted as Proprietary Name for SGX301…
By David Bautz, PhD
NASDAQ:SNGX
READ THE SNGX RESEARCH REPORT
LGIQ: The Plan Comes Together: Revenues and Margins Improve Sequentially in Q1 2021
By Lisa Thompson
OTC:LGIQ
READ THE FULL LGIQ RESEARCH REPORT
EDSA: Nearing Enrollment Completion for Phase 2 Portion of EB05 Trial in COVID-19…
By David Bautz, PhD
NASDAQ:EDSA
READ THE FULL EDSA RESEARCH REPORT
EEIQ: Expanding A Successful Model To New Markets and New Channels
By M. Marin
NASDAQ:EEIQ
READ THE FULL EEIQ RESEARCH REPORT